Zacks Investment Research
17 Jul 2026, 15:47 UTC · 59m ago
Viking Therapeutics to Report Q2 Earnings: What's in Store for the Stock?
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
17 Jul 2026, 15:47 UTC · 59m ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
Viking Therapeutics is expected to report results from its subcutaneous (SC) maintenance dosing study for obesity drug VK2735 in the third quarter of 2026. — Clinical trial data for obesity treatments is a primary catalyst for biotech valuations and can lead to significant price swings.
+0.60Viking Therapeutics plans to initiate a late-stage program for the oral version of VK2735 in the fourth quarter of 2026. — Progressing toward late-stage trials for an oral obesity drug increases the commercial potential and attractiveness of the pipeline.
+0.40The company's earnings have missed expectations in each of the trailing four quarters, with a negative average surprise of 36.70%. — Consistent earnings misses indicate a trend of underperformance relative to analyst expectations, though typical for pre-revenue biotech.
-0.20Continue reading
6 related stories
Top 3 movers · tap to explore
Data from the VANQUISH-1 and VANQUISH-2 late-stage studies for VK2735 is not expected until next year. — The lack of immediate data from primary late-stage studies limits the potential for a near-term positive catalyst.
-0.10Which stocks this story touches
The company has missed earnings expectations for four consecutive quarters and has a 'dismal' recent performance record.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Seeking Alpha
4h ago
